FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称XEVINAPANT
异名/同义词(5S,8S,10AR)-N-(DIPHENYLMETHYL)-5-((2S)-2-(METHYLAMINO)PROPANAMIDO)-3-(3-METHYLBUTANOYL)-6-OXODECAHYDROPYRROLO(1,2-A)(1,5)DIAZOCINE-8-CARBOXAMIDE
AT-406
D-1143
DEBIO 1143
DEBIO-1143
IAP INHIBITOR AT-406
MSC2735845A
PYRROLO(1,2-A)(1,5)DIAZOCINE-8-CARBOXAMIDE, N-(DIPHENYLMETHYL)DECAHYDRO-5-(((2S)-2-(METHYLAMINO)-1-OXOPROPYL)AMINO)-3-(3-METHYL-1-OXOBUTYL)-6-OXO-, (5S,8S,10AR)-
SM-406
XEVINAPANT
XEVINAPANT [INN]
XEVINAPANT [USAN]
XEVINAPANT [WHO-DD]
CAS登记号1071992-99-8
物质唯一标识(Unique Ingredient Identifier)N65WC8PXDD
分子式C32H43N5O4
国际化合物标识(International Chemical Identifier,InChI)LSXUTRRVVSPWDZ-MKKUMYSQSA-N
SMILESC(NC(c1ccccc1)c2ccccc2)(=O)[C@H]3N4[C@](CC3)(CCN(C[C@@H](C4=O)NC([C@@H](NC)C)=O)C(CC(C)C)=O)[H]
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System